Cargando…
Ensuring a high-quality and resilient supply chain of essential medications means paying more
Several medications that patients need have been in short supply before and during the COVID-19 pandemic, including low-priced, off-patent generic drugs. The White House recently released a report highlighting medication supply as an important issue requiring intervention. We argue the report’s prop...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372977/ https://www.ncbi.nlm.nih.gov/pubmed/35471068 http://dx.doi.org/10.18553/jmcp.2022.28.5.573 |